Showing 1 - 10 of 47,294
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10010326193
Persistent link: https://www.econbiz.de/10009720772
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10011257622
Persistent link: https://www.econbiz.de/10011542205
Objective: To study how changes in insurance benefit design affect medication use of older adults with mental disorders.Data sources: US Medicare claims data from 2007 to 2018.Study Design: We focus on the gradual elimination of the Medicare prescription drug coverage gap beginning in 2011, and...
Persistent link: https://www.econbiz.de/10012549072
-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …
Persistent link: https://www.econbiz.de/10010489291
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10013121905
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10014178520
Reference price systems for prescription drugs constitute widely adopted cost containment tools. In these systems, patients co-pay a fraction of the difference between a drug's pharmacy retail price and a reference price that is set by the government. Reference prices are either determined...
Persistent link: https://www.econbiz.de/10009751931
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10009717701